Roden M, Price T B, Perseghin G, Petersen K F, Rothman D L, Cline G W, Shulman G I
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
J Clin Invest. 1996 Jun 15;97(12):2859-65. doi: 10.1172/JCI118742.
To examine the mechanism by which lipids cause insulin resistance in humans, skeletal muscle glycogen and glucose-6-phosphate concentrations were measured every 15 min by simultaneous 13C and 31P nuclear magnetic resonance spectroscopy in nine healthy subjects in the presence of low (0.18 +/- 0.02 mM [mean +/- SEM]; control) or high (1.93 +/- 0.04 mM; lipid infusion) plasma free fatty acid levels under euglycemic (approximately 5.2 mM) hyperinsulinemic (approximately 400 pM) clamp conditions for 6 h. During the initial 3.5 h of the clamp the rate of whole-body glucose uptake was not affected by lipid infusion, but it then decreased continuously to be approximately 46% of control values after 6 h (P < 0.00001). Augmented lipid oxidation was accompanied by a approximately 40% reduction of oxidative glucose metabolism starting during the third hour of lipid infusion (P < 0.05). Rates of muscle glycogen synthesis were similar during the first 3 h of lipid and control infusion, but thereafter decreased to approximately 50% of control values (4.0 +/- 1.0 vs. 9.3 +/- 1.6 mumol/[kg.min], P < 0.05). Reduction of muscle glycogen synthesis by elevated plasma free fatty acids was preceded by a fall of muscle glucose-6-phosphate concentrations starting at approximately 1.5 h (195 +/- 25 vs. control: 237 +/- 26 mM; P < 0.01). Therefore in contrast to the originally postulated mechanism in which free fatty acids were thought to inhibit insulin-stimulated glucose uptake in muscle through initial inhibition of pyruvate dehydrogenase these results demonstrate that free fatty acids induce insulin resistance in humans by initial inhibition of glucose transport/phosphorylation which is then followed by an approximately 50% reduction in both the rate of muscle glycogen synthesis and glucose oxidation.
为研究脂质在人体内引起胰岛素抵抗的机制,在正常血糖(约5.2 mM)高胰岛素(约400 pM)钳夹条件下,对9名健康受试者在低(0.18±0.02 mM [平均值±标准误];对照)或高(1.93±0.04 mM;脂质输注)血浆游离脂肪酸水平下,每隔15分钟通过同时进行的13C和31P核磁共振波谱法测量骨骼肌糖原和葡萄糖-6-磷酸浓度,持续6小时。在钳夹的最初3.5小时内,全身葡萄糖摄取率不受脂质输注的影响,但随后持续下降,6小时后降至对照值的约46%(P<0.00001)。脂质氧化增强伴随着从脂质输注第三小时开始氧化葡萄糖代谢降低约40%(P<0.05)。在脂质输注和对照输注的前3小时,肌肉糖原合成速率相似,但此后降至对照值的约50%(4.0±1.0对9.3±1.6 μmol/[kg·min],P<0.05)。血浆游离脂肪酸升高导致肌肉糖原合成减少之前,从约1.5小时开始肌肉葡萄糖-6-磷酸浓度下降(195±25对对照:237±26 mM;P<0.01)。因此,与最初假设的机制不同,即游离脂肪酸被认为通过最初抑制丙酮酸脱氢酶来抑制胰岛素刺激的肌肉葡萄糖摄取,这些结果表明,游离脂肪酸在人体内诱导胰岛素抵抗是通过最初抑制葡萄糖转运/磷酸化,随后肌肉糖原合成速率和葡萄糖氧化均降低约50%。